Madrigal: Rezdiffra Shift To F4c MASH Cirrhosis Continues With 2-Year Data

Rezdiffra FDA approval fuels sales; expansion to F4 MASH cirrhosis with 2027 trial data. Read more about MDGL stock here.
eLife

A default silencing mechanism restrains stress-induced genes in C. elegans

This valuable study identifies a novel regulator of stress-induced gene quiescence in C. elegans: the multi-Zinc-finger protein ZNF-236. The work provides evidence for an active mechanism that ...
Amazon S3 on MSN

The secret F13-F24 keyboard keys and what they do

ThioJoe explains why function keys from F13 to F24 exist and how they can still be used. A military operation Americans ...
motorsport.com on MSN

What F1 2026's new terminology and technology all means

F1's 2026 season brings plenty of new elements to the table. To ensure no viewers are left in the dark by the season's ...